Phase III studies of brexpiprazole in patients with bipolar I disorder do not meet primary endpoint Feb. 15, 2019
BioArctic's evaluation of SC-0806 for complete spinal cord injury progresses into phase II Feb. 13, 2019
Plasma BACE1 protein as a new biomarker for the diagnosis of cerebral amyloid angiopathy Feb. 13, 2019
Pharmazz presents preliminary phase II data for PMZ-1620 in patients with cerebral ischemic stroke Feb. 13, 2019
RSS